|
| |
BioPortfolio's Approved Drugs DatabaseXalatanLatanoprostDownload PDF containing detailed information.
Press Releases About Xalatan:
|
 |
| Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value |
26th February, 2009 |
NicOx |
SOPHIA ANTIPOLIS, France, February 26 /PRNewswire-FirstCall/ -- NicOx
S.A. (NYSE Euronext Paris: COX) today announced its financial results for
full year 2008 and provided an overview of the
|
| NicOx Reports Results for the First Three Quarters of 2008 |
22nd October, 2008 |
NicOx |
SOPHIA ANTIPOLIS, France, October 22 /PRNewswire-FirstCall/ -- NicOx S.A.
(Euronext Paris: COX) today reported financial results for the nine months
ended September 30, 2008.
Key highlights
|
| First Half 2008 Financial Results: NicOx Nears Completion of Phase 3 Naproxcinod Studies |
28th July, 2008 |
NicOx |
SOPHIA ANTIPOLIS, France, July 28 /PRNewswire-FirstCall/ -- NicOx S.A.
(Euronext Paris: COX) today reported its financial results for the six months
ended June 30, 2008.
Key highlights for
|
Companies working in the area of Xalatan from Bioportfolio's Biocorporate database : | |
| Company Name | |
Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. Pharmacia have built a portfolio of outstanding products, led by key growth drivers: CELEBREX® (celecoxib...
www.pharmacia.com/ View full profile
| |
Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. Pharmacia have built a portfolio of outstanding products, led by key growth drivers: CELEBREX® (celecoxib...
www.biotech.pharmacia.se/ View full profile
| |
Pharmacia is a top-tier global pharmaceutical company, with a leading agricultural subsidiary. We have built a portfolio of outstanding products, led by our key growth drivers: CELEBREX® (celecoxib...
www.pharmacia.com/ View full profile
| | →View more Xalatan related companies. |
This page has been viewed 61 times
Recent Search Terms used to find this page: WHY IS XALATAN LESS EXPENSIVE IN pARIS | global pharma products 2008 xalatan | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Xalatan across BioPortfolio, or for Xalatan Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
